Uptake of novel systemic therapy: Real world patterns among adults with advanced non-small cell lung cancer

INTRODUCTION/BACKGROUND: Systemic treatment for advanced non-small cell lung cancer (NSCLC) is shifting from platinum-based chemotherapy to immunotherapy and targeted therapies associated with improved survival in clinical trials. As new therapies are approved for use, examining variations in use fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Carroll, Nikki M., Eisenstein, Jennifer, Burnett-Hartman, Andrea N., Greenlee, Robert T., Honda, Stacey A., Neslund-Dudas, Christine M., Rendle, Katharine A., Vachani, Anil, Ritzwoller, Debra P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10528526/
https://www.ncbi.nlm.nih.gov/pubmed/37352588
http://dx.doi.org/10.1016/j.ctarc.2023.100730

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10528526/
https://www.ncbi.nlm.nih.gov/pubmed/37352588
http://dx.doi.org/10.1016/j.ctarc.2023.100730

Ejemplares similares